Showing results (11-20 of 259) with videos related to
Sort By:
Pageof 26
American Journal of Hematology|May 13, 2015
Survival outcomes of secondary cancers in patients with Waldenström macroglobulinemia: An analysis of the SEER databaseJorge J Castillo, Adam J Olszewski, Sandra Kanan, et al.Cancer|March 12, 2015
Incidence of secondary malignancies among patients with Waldenström macroglobulinemia: An analysis of the SEER databaseJorge J Castillo, Adam J Olszewski, Zachary R Hunter, et al.Best Practice & Research. Clinical Haematology|November 10, 2016
Future therapeutic options for patients with Waldenström macroglobulinemiaJorge J Castillo, Zachary R Hunter, Guang Yang, et al.British Journal of Haematology|December 19, 2014
Overall survival and competing risks of death in patients with Waldenström macroglobulinaemia: an analysis of the Surveillance, Epidemiology and End Results databaseJorge J Castillo, Adam J Olszewski, Sandra Kanan, et al.British Journal of Haematology|May 8, 2014
Transcriptional repression of plasma cell differentiation is orchestrated by aberrant over-expression of the ETS factor SPIB in Waldenström macroglobulinaemiaYangsheng Zhou, Xia Liu, Lian Xu, et al.Blood|May 14, 2011
Long-term follow-up of symptomatic patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinemia treated with the anti-CD52 monoclonal antibody alemtuzumabSteven P Treon, Jacob D Soumerai, Zachary R Hunter, et al.Clinical Lymphoma, Myeloma & Leukemia|March 26, 2013
Patients with Waldenström macroglobulinemia commonly present with iron deficiency and those with severely depressed transferrin saturation levels show response to parenteral iron administrationSteven P Treon, Christina K Tripsas, Bryan T Ciccarelli, et al.British Journal of Haematology|May 28, 2011
Maintenance Rituximab is associated with improved clinical outcome in rituximab naïve patients with Waldenstrom Macroglobulinaemia who respond to a rituximab-containing regimenSteven P Treon, Christina Hanzis, Robert J Manning, et al.Blood|January 24, 2018
Extracellular vesicle-mediated transfer of constitutively active MyD88L265P engages MyD88wt and activates signalingMateja Manček-Keber, Duško Lainšček, Mojca Benčina, et al.Pageof 26